Treatment of Drug Eruptions
Initial Management
- The British Journal of Dermatology recommends stopping all suspected medications immediately upon recognition of a drug eruption, as this is the cornerstone of management and directly impacts prognosis 1, 2
- Obtaining a thorough drug history covering the previous 2 months, including over-the-counter medications, complementary therapies, and the exact dates when treatments were started, is crucial for management 3
- Documenting the index date (when first symptoms appeared) and progression of the eruption is essential for monitoring and treatment adjustment 3
Severity-Based Treatment Approach
- For localized or mild eruptions, the Annals of Oncology suggests applying topical moderate-to-high potency corticosteroids (such as mometasone furoate 0.1% or betamethasone valerate 0.1% ointment) twice daily to affected areas 4, 5
- The Annals of Oncology recommends using oral antihistamines for symptomatic relief of pruritus: second-generation agents like loratadine 10 mg daily for daytime, or first-generation agents like diphenhydramine 25-50 mg or hydroxyzine 25-50 mg for nighttime sedation 4, 5
- For widespread or intense eruptions, continuing topical high-potency corticosteroids and adding GABA agonists (pregabalin 25-150 mg daily or gabapentin 900-3600 mg daily) as second-line therapy for persistent pruritus unresponsive to antihistamines is recommended 4, 5, 6
- The Journal of Allergy and Clinical Immunology suggests considering systemic corticosteroids (prednisone 0.5-1 mg/kg body weight) for severe cases, though use cautiously as they may be deleterious in advanced toxic epidermal necrolysis 7
Specific Drug Eruption Types
- For papulopustular rashes from targeted cancer therapies, the Journal of Allergy and Clinical Immunology and the Annals of Oncology recommend initiating oral antibiotics for 6 weeks (doxycycline 100 mg twice daily, minocycline 50 mg twice daily, or oxytetracycline 500 mg twice daily) combined with topical low-to-moderate potency steroids 7, 8
- For palmar-plantar eruptions from chemotherapy, the Annals of Oncology suggests applying cooling measures (cold gloves or socks) during infusions for drugs like paclitaxel, docetaxel, and liposomal doxorubicin 6
- The British Journal of Dermatology recommends stopping the offending drug (particularly thiol drugs, phenol drugs, or other implicated agents) for blistering eruptions resembling pemphigus 1, 2
- Recognizing that 50% of cases will resolve with drug withdrawal alone (drug-triggered pemphigus), while the other 50% will require treatment as idiopathic pemphigus, is crucial for management 1, 2